Kim Parnell

97PUBLICATIONS
144CO-AUTHORS
PharmacogenomicsEpidemiological methodsDisease surveillanceClinical psychologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Jul 14, 2026
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials.

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Dec 10, 2025
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis.

Joseph F Merola, Lyn Guenther, Charles Lynde

|Oct 24, 2025
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Kim A Papp, James Q Del Rosso, Mark G Lebwohl

|Oct 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

Matthias Augustin, Marie Tauber, Robert Sidbury

|Oct 09, 2025
Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative Review.

Charles W Lynde, Vimal H Prajapati, Melinda J Gooderham

Pageof 17

Frequent Collaborators

17 joint publications

Melinda J Gooderham

15 joint publications

Andrew Blauvelt

10 joint publications

Jonathan I Silverberg

9 joint publications

Ronald Vender